Clinical trials

  • OncoFAP-23 radiolabelled with lutetium-177 for FAP-positive metastatic solid tumors
  • RADIPRODIL for GRIN-related neurodevelopmental disorder
  • NIPOCALIMAB for Fetal and neonatal alloimmune thrombocytopenia
  • IFINATAMAB DERUXTECAN for Esophageal squamous cell carcinoma
  • OXYTOCIN for Schizophrenia spectrum disorders
  • IFINATAMAB DERUXTECAN for Small cell lung cancer (extensive-stage)
  • encorafenib for Solid tumors
  • OXYGEN for Acute hamstring injury
  • Inotuzumab ozogamicin for Relapsed precursor B-cell acute lymphoblastic leukemia (relapsed B-cell precursor ALL)
  • ALN-961583 for Cerebral amyloid angiopathy | Dutch-type cerebral amyloid angiopathy
  • BETAHISTINE DIHYDROCHLORIDE for Meniere's disease
  • BIO89-100 for Metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis | Nonalcoholic steatohepatitis (NASH) with fibrosis